Mizuho lowered the firm’s price target on Cooper Companies (COO) to $105 from $120 and keeps an Outperform rating on the shares as part of a Q1 preview for the medical devices and diagnostics group. The firm views tariffs, China exposure, and the latest procedure outlook as the key themes heading into the quarter. It cut numbers preemptively.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COO:
- Cooper Co: Strategic Positioning and Market Dynamics Present a Compelling Buy Opportunity
- Morgan Stanley says Planned Parenthood cuts likely immaterial for Cooper
- Hold Rating for Cooper Co Amid Minimal Impact from Planned Parenthood Funding Cuts
- Cooper Companies management to meet with Piper Sandler
- Cooper Co: A Compelling Buy Amid Market Uncertainties and Attractive Valuation
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue